Carriers of the C9orf72 repeat expansion showed a trend of shorter survival compared to non‐carriers; however, the difference was not statistically significant (HR 1.8, CI 95% 0.93–3.5, P = 0.080) (Fig. 2B ).
← all excerpts
Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.
1
—
—